Brief: Enteris Biopharma Presents Study Of Ovarest

SWK Holdings

26/10/2022 14:30

Oct 26 (Reuters) - SWK Holdings Corp  SWKH.O :
    * ENTERIS BIOPHARMA PRESENTS STUDY OF OVAREST® DEMONSTRATING
ORAL
DELIVERY COMPARABLE TO OR EXCEEDING INJECTABLE LEUPROLIDE

Source text for Eikon:  ID:nPn4Rvg80a 
Further company coverage:  SWKH.O 
 ((Reuters.Briefs@thomsonreuters.com;))